Nektar Therapeutics
NKTR
$73.32
-$2.12-2.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 684.34M | 568.60M | 245.75M | 270.21M | 175.90M |
| Total Receivables | 4.76M | 3.60M | 1.78M | 1.29M | 1.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.16M | 2.78M | 2.20M | 2.36M | 1.73M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 48.15M | 14.06M | 16.54M | 7.50M | 7.58M |
| Total Current Assets | 739.40M | 589.04M | 266.27M | 281.36M | 186.57M |
|
|
|||||
| Total Current Assets | 739.40M | 589.04M | 266.27M | 281.36M | 186.57M |
| Net Property, Plant & Equipment | -- | -- | 5.00M | 10.00M | 10.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.67M | 11.24M | 5.65M | 5.16M | 5.02M |
| Total Assets | 1.10B | 763.27M | 280.41M | 301.35M | 207.53M |
|
|
|||||
| Total Accounts Payable | 24.89M | 10.03M | 10.77M | 15.56M | 14.28M |
| Total Accrued Expenses | 19.88M | 22.09M | 19.64M | 25.45M | 31.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 22.71M | 22.53M | 20.50M | 22.18M | 22.01M |
| Total Finance Division Other Current Liabilities | 3.51M | 3.07M | 2.63M | 3.15M | 3.28M |
| Total Other Current Liabilities | 3.51M | 3.07M | 2.63M | 3.15M | 3.28M |
| Total Current Liabilities | 70.99M | 57.71M | 53.54M | 66.34M | 71.39M |
|
|
|||||
| Total Current Liabilities | 70.99M | 57.71M | 53.54M | 66.34M | 71.39M |
| Long-Term Debt | 57.38M | 60.27M | 63.16M | 75.16M | 80.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.85M | 60.63M | 65.26M | 69.73M | 74.15M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.80M | 8.45M | 8.63M | 5.03M | 5.64M |
| Total Liabilities | 192.01M | 187.06M | 190.57M | 216.26M | 231.75M |
|
|
|||||
| Common Stock & APIC | 4.75B | 4.38B | 3.85B | 3.81B | 3.67B |
| Retained Earnings | -3.85B | -3.81B | -3.76B | -3.72B | -3.69B |
| Treasury Stock & Other | -1.76M | -1.03M | 17.00K | 56.00K | -3.01M |
| Total Common Equity | 903.12M | 576.22M | 89.83M | 85.09M | -24.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 903.12M | 576.22M | 89.83M | 85.09M | -24.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 903.12M | 576.22M | 89.83M | 85.09M | -24.21M |
|
|
|||||